The pharmaceutical industry's relentless pursuit of novel treatments hinges on the availability of specialized chemical intermediates. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying such crucial materials, with 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine (CAS: 90213-66-4) standing out as a cornerstone for innovation. This compound is widely recognized for its pivotal role in the synthesis of Tofacitinib citrate, a significant therapeutic agent.

Understanding the chemical profile of 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine is key to appreciating its value. Possessing the molecular formula C6H3Cl2N3 and a molecular weight of 188.01400, this compound is an off-white to yellow solid with a well-defined melting point (247-250°C). Its structural features, particularly the pyrrolo-pyrimidine core, make it a highly versatile component in organic synthesis. NINGBO INNO PHARMCHEM CO.,LTD. ensures that this intermediate is supplied at high purity, typically ≥99%, meeting the stringent demands of pharmaceutical development. This focus on providing high purity organic synthesis intermediates is fundamental to our mission.

The primary application of 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine is its critical function in the Tofacitinib citrate synthesis. As a key intermediate, it enables the efficient construction of the complex molecular structure of this JAK inhibitor, which is vital for managing autoimmune diseases. The reliability of the chemical synthesis process for this intermediate directly impacts the scalability and cost-effectiveness of Tofacitinib production. NINGBO INNO PHARMCHEM CO.,LTD. is committed to optimizing pyrrolo-pyrimidine synthesis pathways to meet growing global demand.

As specialists in organic synthesis building blocks, NINGBO INNO PHARMCHEM CO.,LTD. empowers pharmaceutical companies with the materials they need for groundbreaking research and development. The compound's adaptable nature allows it to serve as a platform for exploring new chemical entities with potential therapeutic benefits, driving forward the field of drug discovery. The consistent availability of reliable CAS 90213-66-4 suppliers is essential for researchers to maintain momentum in their projects.

NINGBO INNO PHARMCHEM CO.,LTD. actively contributes to the pharmaceutical sector by providing high-quality intermediates that facilitate the development of advanced medical treatments. Our expertise in fine chemical manufacturing underscores our commitment to supporting global health initiatives. By ensuring a stable and high-quality supply of compounds like 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine, we aim to accelerate the journey from laboratory discovery to patient care.